JL

John Lewis

Bird Dogs Chair in Translational Cancer Research at University of Alberta
Request removal
Email: ****s@ualberta.ca
LinkedIn: John Lewis
Location: Edmonton, Alberta, Canada
Current employer: Aegis Life, Inc.
Current title:
Founder, CEO
Last updated: 04/06/2024 11:56 AM
Get valid emails for John and 500M other professionals
20 free emails each month. No credit card required.
500M
Business Profiles
20M
Company Profiles
200M
Email addresses
98%+
Email Delivery
About

John Lewis is from Edmonton, Alberta, Canada. John is currently Founder, CEO at Aegis Life, Inc., located in San Diego, California, United States. John also works as Founder, CEO at Nanostics Inc, a job John has held since Jan 2017. Another title John currently holds is Founder, CEO at Entos Pharmaceuticals.

John Lewis's email is available on Finalscout.com free of charge. This database has a wealth of information on over half a billion business professionals and two hundred million companies.

John Lewis's current jobs
Company: Aegis Life, Inc.
Title: Founder, CEO
Period: Sep 2020 - Present (4 years, 2 months)
Location: San Diego, California, United States
Company: Nanostics Inc
Title: Founder, CEO
Period: Jan 2017 - Present (7 years, 10 months)
Location: Edmonton, Alberta, Canada

Nanostics is a healthcare biotechnology company focused on development and commercialization of novel, non-invasive diagnostic tests. Our core technology is an advanced liquid biopsy platform that combines an advanced machine learning approach with extracellular vesicle analysis to accurately diagnose disease from a single drop of blood. Our lead product, ClarityDX Prostate, is the most accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the world’s leading diagnostic tool for prostate cancer.

Title: Founder, CEO
Period: May 2016 - Present (8 years, 6 months)
Location: Edmonton, Alberta, Canada

Entos Pharmaceuticals develops next generation nucleic acid-based therapies using the proprietary Fusogenix proteo-lipid vehicle (PLV) drug delivery system. Fusogenix uses a novel mechanism of action to deliver molecules, intact and unmodified, directly into the cytosol of target cells. Unlike conventional lipid-based delivery, Fusogenix is well tolerated at high systemic doses, and retains maximal activity with repeat dosing. Entos has developed unique formulations to effectively deliver a wide range of genetic therapies, including gene therapy, mRNA, miRNA, RNAi and CRISPR.

John Lewis's education
The Scripps Research Institute
PDF
2003 - 2006
University of Victoria
Ph.D.
1996 - 2003
The University of Western Ontario
BSc HONS
1989 - 1993
Other people named John Lewis
JL
John Lewis
Level Designer
JL
John Lewis
Construction Manager
South Marylebone, England, United Kingdom
JL
John Lewis
Program Manager
Strand, England, United Kingdom
JL
John Lewis
Director - Cybersecurity and Infrastructure
Houston, Texas, United States
JL
John Lewis
There are 4.5K+ other "John Lewis". You can find all of them in FinalScout.
Scrape emails from LinkedIn for free
20 free emails each month. No credit card required.
Regular search results
Search for leads on linkedin.com and scrape the search results
Sales Navigator search results
Search for leads in LinkedIn sales navigator and scrape the search results
Group members
Scrape members from any LinkedIn group without joining it
Event attendees
Scrape event attendees from any LinkedIn event
Directory